This effect takes place through several pharmacodynamic mechanisms including an increase in PPARγ nuclear translocation and its expression, a decrease in tumor markers expression, and, on the other hand, acting as a strong epigenetic regulator through the possible formation of PPARγ-DNMT1 complex, preventing DNA hypomethylation observed in HCC. This evidence concerns the gene PPARG and neoplasm.